Cardiovascular Imaging Heart Disease Stenosis 
DAIC
MARCH 28, 2024
milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.
Circulation
NOVEMBER 13, 2024
Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of leading to coronary artery dilation and coronary artery aneurysms in 25% of untreated patients.
DAIC
FEBRUARY 13, 2024
Cleerly, a digital healthcare company focused on heart disease, has announced continued strong scientific evidence supporting the clinical utility of its products, detailing a study published online on Jan. 25, 2024 in the European Heart Journal Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging.
DAIC
JANUARY 17, 2024
Christian Tesche (Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina and Department of Cardiology, Munich University Clinic, Ludwig-Maximilian-University).
Circulation: Cardiovascular Imaging
JANUARY 13, 2025
Circulation: Cardiovascular Imaging, Ahead of Print. Disorders of the pulmonic valve (PV) receive considerably less attention than other forms of valvular heart disease.
DAIC
APRIL 2, 2024
approval of TriClip is a significant advancement for people suffering from tricuspid regurgitation, a heart condition that negatively impacts their quality of life and puts them at grave risk of serious health issues," said Paul Sorajja, M.D. , the Roger L. and Lynn C. important safety information on TriClip, visit [link].
Expert insights. Personalized for you.
110 
Let's personalize your content